Enveda Therapeutics
Clinical trials sponsored by Enveda Therapeutics, explained in plain language.
-
New eczema drug trial seeks to tame itchy skin
Disease control Recruiting nowThis study is testing whether a new oral medication called ENV-294 can safely reduce the severity and extent of moderate-to-severe eczema (atopic dermatitis) in adults. For 12 weeks, 64 participants will take either the drug or a placebo pill daily, with regular clinic checkups t…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New pill tested to tame severe asthma attacks
Disease control Recruiting nowThis study is testing a new oral drug called ENV-294 to see if it can help adults whose moderate-to-severe asthma is not fully controlled by their current inhalers. About 50 participants will take either the new drug or a placebo pill daily for 12 weeks. Researchers will check if…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC